135 related articles for article (PubMed ID: 27667327)
21. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
[TBL] [Abstract][Full Text] [Related]
23. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
24. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
[TBL] [Abstract][Full Text] [Related]
25. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
[TBL] [Abstract][Full Text] [Related]
26. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
[TBL] [Abstract][Full Text] [Related]
27. [The evaluation of sensitivity and specificity of technique of detection of C-reactive protein under diagnostic of infectious complications in patients with acute lymphoblastic leucosis receiving chemotherapy].
Vladimirova SG; Tarasova LN; Dokshina IA; Cherepanova VA
Klin Lab Diagn; 2014 Nov; 59(11):17-21. PubMed ID: 25850239
[TBL] [Abstract][Full Text] [Related]
28. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
van Vliet MJ; Tissing WJ; Rings EH; Koetse HA; Stellaard F; Kamps WA; de Bont ES
Pediatr Blood Cancer; 2009 Dec; 53(7):1188-94. PubMed ID: 19688831
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
[TBL] [Abstract][Full Text] [Related]
30. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
Raetz EA; Cairo MS; Borowitz MJ; Lu X; Devidas M; Reid JM; Goldenberg DM; Wegener WA; Zeng H; Whitlock JA; Adamson PC; Hunger SP; Carroll WL
Pediatr Blood Cancer; 2015 Jul; 62(7):1171-5. PubMed ID: 25732247
[TBL] [Abstract][Full Text] [Related]
31. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Münster (BFM) protocols.
Lejhancova-Tousovska K; Zapletal O; Vytiskova S; Strbackova P; Sterba J
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):144-54. PubMed ID: 22227959
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D
Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
[TBL] [Abstract][Full Text] [Related]
34. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
35. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
36. Serum vascular endothelial growth factor-a levels during induction therapy in children with acute lymphoblastic leukemia.
Kalra M; Dinand V; Choudhary S; Sachdeva A; Yadav SP
Indian Pediatr; 2013 Jul; 50(7):659-62. PubMed ID: 23502666
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
38. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
40. Surfactant Protein-D: A sensitive predictor for efficiency of preoperative pulmonary rehabilitation.
Huang J; Lai Y; Gao K; Wang Y; Du H; Su J; Che G; Zhou X
Int J Surg; 2017 May; 41():136-142. PubMed ID: 28385654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
